Metropolitan to Urgently Call on Portions of Los Angeles County to Suspend Outdoor Watering Ahead of Major Pipeline Shutdown Next Week
Four million residents and businesses fall under water-saving call Sept. 6-20 as Metropolitan fixes leak…
News
Faraday Future Files Revised Preliminary Proxy Statement and Refutes FF Top’s Proxy
LOS ANGELES–(BUSINESS WIRE)–Faraday Future Intelligent Electric Inc. (“Faraday Future” or the “Company”) (NASDAQ: FFIE), a…
KBRA Releases Research – CMBS Loan Performance Trends: August 2022
NEW YORK–(BUSINESS WIRE)–#KBRA–KBRA releases a report on U.S. commercial mortgage-backed securities (CMBS) loan performance trends…
ArmorText named a Strong Performer, Excels at Out of Band Comms in report by Independent Research Firm
ArmorText received the highest scores possible in nine criteria, including Data Sovereignty, Enhanced Functionality, and…
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Dingdong (Cayman) Limited (DDL) on Behalf of Investors
LOS ANGELES–(BUSINESS WIRE)–Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm,…
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Coupang, Inc. (CPNG) on Behalf of Investors
LOS ANGELES–(BUSINESS WIRE)–Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm,…
UScellular Earns More Than $850,000 Through the ComEd Energy Efficiency Program
CHICAGO–(BUSINESS WIRE)–UScellular and ComEd today announced that UScellular has received $868,000 in incentive payments through…
An Affiliate of Walton Street Originates Loan to the Bainbridge Companies and Virtus Real Estate Capital for the Acquisition of Aventura Crossroads, a Multifamily Community
CHICAGO–(BUSINESS WIRE)–An affiliate of Walton Street Capital, L.L.C. (“Walton Street”) originated a $69.8 million loan…
ACORE Capital Receives Commercial Primary and Special Servicer Ratings from Fitch
SAN FRANCISCO–(BUSINESS WIRE)–ACORE Capital, LP (“ACORE”), one of the leading U.S. commercial real estate debt…
Accenture Completes Acquisition of Eclipse Automation
NEW YORK & TORONTO–(BUSINESS WIRE)–Accenture (NYSE: ACN) has completed its acquisition of Eclipse Automation, a…
Cummins Powered CLAAS TRION Combine to Make North American Debut
BOONE, Iowa–(BUSINESS WIRE)–Visitors to Farm Progress will be able to get their first look at…
Chimerix Awarded BARDA Contract for TEMBEXA as Medical Countermeasure for Smallpox
– Initial Procurement of 319,000 Treatment Courses for $115M with Additional Procurements at BARDA’s Discretion…
Todos Medical Expands COVID Onsite School Sample Collection to Include MonkeyPox Testing
New York, NY, and Tel Aviv, ISRAEL, Aug. 29, 2022 (GLOBE NEWSWIRE) — via NewMediaWire…
Applied StemCell Announces the Expansion of its cGMP Manufacturing Facility to Support Cell and Gene Therapy
MILPITAS, Calif.–(BUSINESS WIRE)–#Bioproduction–Applied StemCell, Inc. (ASC), a leading cell and gene therapy CRO/CDMO focused on…
UEFI Forum Releases the UEFI 2.10 Specification and the ACPI 6.5 Specification
The latest specifications are built for a post-quantum world and will support emerging applications like…
GBS Inc. to Present Fourth Quarter and Full Year 2022 Financial Results and Recent Corporate Update on August 31
Company to Host Conference Call & Webcast at 4:30 p.m. ET NEW YORK, Aug. 29,…
Neuronetics Announces 510(k) Clearance of D-Tect™ MT Accessory for NeuroStar® Advanced Therapy for Mental Health
Latest NeuroStar innovation to simplify the motor threshold determination for clinicians MALVERN, Pa., Aug. 29,…
Galecto Announces Publication Supporting the Predictive Role of Galectin-3 on Overall Survival of NSCLC Patients in Peer-Reviewed Scientific Journal
BOSTON, Aug. 29, 2022 (GLOBE NEWSWIRE) — Galecto, Inc. (NASDAQ: GLTO), a clinical stage biotechnology…
Gradalis Announces Publication in Nature Communications Medicine Identifying Survival Predicting Biomarker in Patients with Ovarian Cancer Treated with Vigil®
Analysis identified high expression of ENTPD1 gene in patients at baseline as a significant predictor…
TRACON Pharmaceuticals Announces Approval of IND for CTLA-4 Antibody YH001 for the Treatment of Front-line Sarcoma Patients in Combination with Envafolimab
SAN DIEGO, Aug. 29, 2022 (GLOBE NEWSWIRE) — TRACON Pharmaceuticals, Inc. (Nasdaq: TCON), a clinical…